Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
4
×
boston blog main
clinical trials
life sciences
national blog main
national top stories
biotech
boston top stories
deals
fda
new york blog main
new york top stories
amgen
inclisiran
new york
novartis
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sanofi
abbvie
akouos
alexion pharmaceuticals
alirocumab
allergan
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
cholesterol
covid-19
What
medicines
4
×
drug
cholesterol
deal
fda
medco
acquire
acquisitions
agreed
announced
billion
bio
bringing
brings
cash
caught
causing
ceo
clears
closer
collabs
company
compound
covid
daniel
dicerna
disease
eye
filing
gene
gilead
gilead’s
help
hepatitis
inched
intended
introduce
ipo
lowering
market
Language
unset
4
×
Current search:
medicines
×
" alnylam pharmaceuticals "
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests